Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator?

Digestive Surgery

Volumn 18, Issue 2, 2001, Pages 111-117

  Moriwaki, Yoshihiro ^a,b   Kobayashi, Syunsuke ^a   Kunisaki, Chikara ^a   Harada, Hirofumi ^a   Imai, Sinsuke ^a   Kido, Yasuhiro ^a   Kasaoka, Chitaka ^a  

^a FUJISAWA CITY HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

D2 lymphadenectomy; Gastric cancer; Long term survival; Operating skill; Postoperative complications

Indexed keywords

ADULT; AGED; ARTICLE; COMPETENCE; FEMALE; GASTRECTOMY; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; SAFETY; SURGEON; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE;

ADULT; AGED; BLOOD LOSS, SURGICAL; CLINICAL COMPETENCE; FEMALE; GASTRECTOMY; HOSPITAL MORTALITY; HOSPITALS, MUNICIPAL; HUMANS; JAPAN; LYMPH NODE EXCISION; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; PROGNOSIS; SAFETY; STOMACH NEOPLASMS; SURGERY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035025286     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050110     Document Type: Article

References (43)

1. Shiu MH, Moore E, Sanders M, Huvos A, Freedman B, Goodbold J, Chaiyaphruk S, Wesdorp R, Brennan MF: Influence of the extent of resection on survival after curative treatment of gastric carcinoma. Arch Surg 1987;122:1347-1351.
2. Shiu MH, Perrotti M, Brennan MF: Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathological and treatment factors. Hepato-gastroenterology 1989;36:7-12.
3. Robertson CS, Chung SCS, Woods SDS, Griffin SM, Raimes SA, Lau JTF, Li AKC: A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220:176-182.
4. Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK: Gastric carcinoma: Does lymph node dissection alter survival? J Am Coll Surg 1996;183:616-624.
5. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomized controlled surgical trial. Lancet 1996;347:995-999.
6. Centiagoya GF, Bergh CK, Klinger-Roitman J: A prospective study of gastric cancer. Dig Surg 1998;15:317-322.
7. Roukos DH, Lorenz M, Eneke A: Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: A prospective long-term follow-up study. Surgery 1998;123:573-578.
8. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma (English ed 1). Tokyo, Kanchara & Co. 1995.
9. Dent DM, Madden MV, Price SK: Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988;75:110-112.
10. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JTM, van Elk P, Oberlop H, Gouma DJ, Taat CW, van Lanschot J, Mover S, de Graaf PW, von Meyenfeldt MF, Tilanus H, van de Velde CJH: Randomized complication of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-748.
11. Parikh D, Johnson M, Chagla L, Lowe D, McCulloch P: D2 gastrectomy: Lesson from a prospective audit of the learning curve. Br J Surg 1996;83:1595-1599.
12. Soreide JA, van Heerden JA, Burgart LJ, Donohue JH, Sarr MG, Ilstrup DM: Surgical aspects of patients with adenocarcinoma of the stomach operated on for cure. Arch Surg 1996; 131:481-487.
13. Smith JW, Shiu MH, Kelsey L, Brennan MF: Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991;126:1469-1473.
14. Jaehne J, Meyer HJ, Masehek H, Geerlings H, Bruns E, Pichlmayr R: Lymphadenectomy in gastric carcinoma: A prospective and prognostic study. Arch Surg 1992;127:290-294.
15. Roder JD, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ, and German Gastric Carcinoma Study Group: Prognostic factors in gastric carcinoma: Results of the German Gastric Carcinoma Study 1992. Cancer 1993;72: 2089-2097.
16. Mendes de Almeida JC, Bettencourt A, Costa CS, Mendes de Almeida JM: Curative surgery for gastric cancer: Study of 166 consecutive patients. World J Surg 1994;18:889-895.
17. Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C: Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996;83:1604-1607.
18. Sanchez-Bueno F, Garcia-Marcilla JA, Perez-Flores D, Perez-Abad JM, Vicente R, Aranda F, Ramirez P, Parrilla P: Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998;85:255-260.
19. Burmeister R: Long-term survival in cases of early and advanced gastric cancer in Chile. Gann Monogr Cancer Res 1986;31:165-170.
20. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F: Extensive versus limited lymph node dissection for gastric cancer: A comparative study of 320 patients. Br J Surg 1993;80:1153-1156.
21. Sue-Ling HM, Johnston D, Martin IG, Dixon MF, Lansdown MRJ, McMahon MJ, Axon ATR: Gastric cancer: A curable disease in Britain. BMJ 1993;307:591-596.
22. Böttcher K, Siewert JR, Roder JD, Busch R, Hermanek P, Meyer HJ: Risiko der chirurgischen Therapie des Magencarcinoms in Deutschland: Ergebnisse der Deutschen Magencarcinom-Studie 1992. Chirurg 1994;65: 298-306.
23. McCulloch P: Should general surgeons treat gastric carcinoma? An audit of practice and results 1980-1985. Br J Surg 1994;81:417-420.
24. Begg CB, Cramer LD, Hoskins WJ, Brennan MF: Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280:1747-1751.
25. Kodama Y, Sugimachi K, Soejima K, Matsusaka T, Inokuchi K: Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 1981;5:241-248.
26. Maruyama K, Okabayashi K, Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11: 418-425.
27. Soga J, Ohyama S, Miyashita K, Suzuki T, Nashimoto A, Tanaka O, Sasaki K, Muto T: A statistical evaluation of advancement in gastric cancer surgery with special reference to the significance of lymphadenectomy for cure. World J Surg 1988;12:398-405.
28. Maruyama K, Gunvén P, Okabayashi K, Sasako M, Kinoshita T: Lymph node metastases of gastric cancer: General pattern in 1,931 patients. Ann Surg 1989;210:596-602.
29. Yonemura Y, Katayama K, Kamata T, Fushida S, Segawa M, Ooyama S, Miwa K, Miyazaki I: Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node. Int Surg 1991;76:222-225.
30. Moriwaki Y, Suda T, Kito F, Imada T, Okada K, Okada T, Fukuzawa K, Akiyama H, Takemura H, Nakamura N: A clinical study on the malignant potential of the remnant gastric cancer. Jpn J Gastroenterol Surg 1993;26:2280-2286.
31. Sasako M, McCulloch P, Kinoshita T, Maruyama K: New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;82:346-351.
32. Isozaki H, Okajima K, Kawashima Y, Yamada S, Nakata E, Nakajima T, Nishimura J, Yoshioka T, Ichinona T, Asaka K: A study on long-term results of surgically treated patients with a ps(-) stomach cancer with a lymph node metastasis. Jpn J Cancer Clin 1991;37:825-832.
33. Nakajima T, Ohta K, Ishihara A, Yamada H, Matsubara T, Nishi M: Chronological changes in the morphologic features of gastric cancer and in surgical treatment. Stomach and Intestine 1993;28:51-58.
34. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T: Feasibility of the staging system and curability classification in the twelfth edition of General Rules for Gastric Cancer Study. J Jpn Clin Surg Assoc 1996;57:788-793.
35. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H: Surgical treatment for gastric cancer: The Japanese approach. Semin Oncol 1996;23: 360-368.
36. Moriwaki Y, Kobayashi S, Harada H, Kunisaki C, Imai S, Kido Y, Kasaoka C: Risk factors for the recurrence of gastric cancer patients in various period after operation. Jpn J Gastroenterol Surg 1998;31:21-26.
37. Siewert JR, Böttcher K, Roder JD, Busch R, Hermanek P, Meyer HJ, and the German Gastric Carcinoma Study Group: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993;80:1015-1018.
38. Bonenkamp JJ, van de Velde CJH, Hermans J: Randomized trial of extended lymph node dissection for gastric cancer; in Siewert JR, Roder JD (eds): 2nd International Gastric Cancer Congress Munich. Bologna, Monduzzi, 1997, vol 2, pp 1111-1116.
39. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Payers P: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Br J Cancer 1999;79: 1522-1530.
40. Bonenkamp JJ, Hermans M, Sasako M, Van de Velde CJH: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340: 908-914.
41. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Crose N, Gennari L, the Italian Gastrointestinal Tumor Study Group: Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trial. Ann Surg 1997;226:613-620.
42. Viste A, Svanes K, Janssen CW Jr, Maartmann-Moe H, Sørcide O: Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer. Eur J Surg 1994; 160:497-502.
43. Judging Committee of Japan Surgical Society: The results of judgement of authorization. J Jpn Surg Soc 1999(12);100:1-4.